Date | Price Target | Rating | Analyst |
---|---|---|---|
8/7/2024 | $58.00 | Market Perform → Market Outperform | CJS Securities |
4/22/2024 | $52.00 → $62.00 | Hold → Buy | Jefferies |
11/6/2023 | $49.00 | Market Outperform → Market Perform | CJS Securities |
10/3/2023 | $62.00 → $53.00 | Buy → Hold | Loop Capital |
8/7/2023 | $71.00 → $60.00 | Outperform → Market Perform | BMO Capital Markets |
7/27/2023 | $64.00 → $75.00 | Hold → Buy | Loop Capital |
5/5/2023 | $92.00 → $64.00 | Buy → Hold | Loop Capital |
2/2/2023 | $81.00 → $100.00 | Hold → Buy | Loop Capital |
10-Q - Ingevity Corp (0001653477) (Filer)
8-K - Ingevity Corp (0001653477) (Filer)
8-K - Ingevity Corp (0001653477) (Filer)
Ingevity Corporation (NYSE:NGVT) will participate in the FEICA European Adhesive & Sealant Conference and EXPO 2024 in Noordwijkerhout, the Netherlands, from September 11-13, 2024. The company will launch Capa® L, the next generation of sustainable and innovative polycaprolactone polyols for polyurethane adhesives that can be used in flexible food packaging, construction and industrial applications. "The latest generation of Capa polyols provides formulators with the performance and sustainability benefits they are seeking," said Ingevity senior vice president and president, Advanced Polymer Technologies, Steve Hulme. "We're excited to debut our newest Capa polyol technology, Capa L, which
Will optimize existing manufacturing footprint by consolidating oleo-based chemical refining with existing crude tall oil refining at the company's North Charleston, South Carolina, facility, and closing its Crossett, Arkansas, facility in August Manufacturing consolidation will result in approximately $20 million to $25 million in annual savings beginning in 2025 Executes corporate and business-related cost reduction actions resulting in additional annual savings of approximately $10 million beginning in 2025 Expects charges associated with these actions of approximately $100 million, with approximately $65 million to be non-cash Continues to evaluate the Performance Chemicals
HIGHLIGHTS: Net sales of $390.6 million, down 19% compared to prior year Net loss of $283.7 million and diluted loss per share of $7.81 primarily due to a Performance Chemicals non-cash goodwill impairment charge; adjusted earnings of $36.8 million and diluted adjusted earnings per share (EPS) of $1.01 Adjusted EBITDA of $101.3 million and adjusted EBITDA margin of 25.9% Operating cash flow of $29.7 million with free cash flow of $11.6 million In July, the company took further actions to reposition its Performance Chemicals segment, including the termination of a long-term crude tall oil supply contract, the announced closure of its Crossett, Arkansas, facility, to consolidat
3 - Ingevity Corp (0001653477) (Issuer)
4 - Ingevity Corp (0001653477) (Issuer)
4 - Ingevity Corp (0001653477) (Issuer)
SC 13D/A - Ingevity Corp (0001653477) (Subject)
SC 13G/A - Ingevity Corp (0001653477) (Subject)
SC 13G - Ingevity Corp (0001653477) (Subject)
Ingevity Corporation (NYSE:NGVT) today announced the appointment of Ryan C. Fisher as senior vice president, general counsel and secretary and Terry Dyer as senior vice president and chief human resources officer. "We are excited to add Ryan and Terry to our executive leadership team," said Ingevity president and CEO, John Fortson. "Both leaders bring extensive experience, with successful track records of leading companies through business growth and expansion. I am confident that their contributions will be instrumental in driving our continued success and innovation." Fisher has held various leadership positions during his 18-year tenure with Ingevity and its predecessors. Most recent
Allegion plc (NYSE:ALLE), a leading global security products and solutions provider, has appointed Stacy Cozad as senior vice president, general counsel and corporate secretary, effective Aug. 5, 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240701071652/en/Stacy Cozad (Photo: Business Wire) In this role, Cozad will have responsibility for Allegion's global legal affairs, trade compliance, enterprise risk management and corporate communications functions. She will succeed Jeff Braun, who has announced plans to retire on Dec. 31, 2024, and will serve as an advisor during the transition. Cozad has nearly 30 years of exper
Ingevity Corporation (NYSE:NGVT) today announced it has named Christine Stunyo, formerly with Host Hotels & Resorts, as chief human resources officer. In this role, Stunyo will be responsible for leading the company's global Human Resources (HR) function, including organization development, integrated talent management, leadership development and culture. She assumes the new role effective June 27, 2022. "We are thrilled to welcome Christine to Ingevity to lead our outstanding human resources team," said John Fortson, Ingevity president and CEO. "She will be instrumental in continuing our commitment to diversity, equity and inclusion, drawing the best talent to Ingevity, and helping to dev
In the preceding three months, 5 analysts have released ratings for Ingevity (NYSE:NGVT), presenting a wide array of perspectives from bullish to bearish. Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 1 3 0 0 Last 30D 0 0 1 0 0 1M Ago 0 0 0 0 0 2M Ago 0 0 0 0 0 3M Ago 1 1 2 0 0 The 12-month price targets, analyzed by analysts, offer insights with an average target of $55.2, a high estimate of $62.00, and a low estimate of $45.00. Observing a 7.81% increase, the current average has risen fro
Wells Fargo analyst Michael Sison maintains Ingevity (NYSE:NGVT) with a Equal-Weight and lowers the price target from $55 to $45.
Will optimize existing manufacturing footprint by consolidating oleo-based chemical refining with existing crude tall oil refining at the company's North Charleston, South Carolina, facility, and closing its Crossett, Arkansas, facility in August Manufacturing consolidation will result in approximately $20 million to $25 million in annual savings beginning in 2025 Executes corporate and business-related cost reduction actions resulting in additional annual savings of approximately $10 million beginning in 2025 Expects charges associated with these actions of approximately $100 million, with approximately $65 million to be non-cash Continues to evaluate the Performance Chemicals
HIGHLIGHTS: Net sales of $390.6 million, down 19% compared to prior year Net loss of $283.7 million and diluted loss per share of $7.81 primarily due to a Performance Chemicals non-cash goodwill impairment charge; adjusted earnings of $36.8 million and diluted adjusted earnings per share (EPS) of $1.01 Adjusted EBITDA of $101.3 million and adjusted EBITDA margin of 25.9% Operating cash flow of $29.7 million with free cash flow of $11.6 million In July, the company took further actions to reposition its Performance Chemicals segment, including the termination of a long-term crude tall oil supply contract, the announced closure of its Crossett, Arkansas, facility, to consolidat
Ingevity Corporation (NYSE:NGVT) announced today that it will release its second-quarter 2024 earnings after the stock market close on Wednesday, July 31, 2024. The company will host a live webcast on Thursday, August 1, at 11:00 a.m. (Eastern) to discuss second-quarter 2024 fiscal results. The webcast can be accessed here or on the investors section of Ingevity's website. You may also listen to the conference call by dialing 833 470 1428 (inside the U.S.) and entering access code 153840. Callers outside the U.S. can find global dial-in numbers here. For those unable to join the live event, a recording will be available beginning at approximately 2:00 p.m. (Eastern) on August 1, 2024, t
CJS Securities upgraded Ingevity from Market Perform to Market Outperform and set a new price target of $58.00
Jefferies upgraded Ingevity from Hold to Buy and set a new price target of $62.00 from $52.00 previously
CJS Securities downgraded Ingevity from Market Outperform to Market Perform and set a new price target of $49.00